Trial Profile
Contrast study of Entecavir monotherapy and the de novo combining Lamivudine with Adefovir therapy on HBeAg-positive CHB patients with high viral load
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Adefovir; Lamivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- 23 Aug 2015 Status changed from recruiting to completed as per Chinese Clinical Trial Register record.
- 16 Jul 2012 New trial record